lobbying_activities: 3485547

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3485547	f47e8740-6d83-4b9e-88f9-b49eb3d1b385	Q4	THE HARPLE GROUP, LLC	401108916	PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION (PILMA)	2025	fourth_quarter	PHA	Prescription drug industry issues relating to domestic construction and maintenance, and prescription drug pricing Pharmacy Benefit Manager Transparency Act of 2023; Prescription Pricing for the People Act of 2023; HELP Copays Act; Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); Lowering Drug Costs for American Families Act; Protecting Patients Against PBM Abuses Act; The Drug Act; Lower Costs, More Transparency Act.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2026-01-15T10:52:20-05:00